To investigate the potential mechanism by which mutated p53 contributes to colorectal cancer development, we divided the COAD patients into wild-type p53 and missense p53 subgroups, and GSEA and cell enrichment analysis were performed on them. Here, TP53 is linked to colon adenocarcinoma.